Účtovná hodnota akcie spoločnosti QSAM Biosciences

Aká je hodnota metriky Účtovná hodnota akcie spoločnosti QSAM Biosciences?

Hodnota metriky Účtovná hodnota akcie spoločnosti QSAM Biosciences, Inc. je -0.01

Aká je definícia metriky Účtovná hodnota akcie?

Účtovná hodnota akcie (Book/Share) sa rovná majetku spoločnosti mínus záväzky spoločnosti podelené počtom vydaných akcií.

The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.

The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.

Účtovná hodnota akcie spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou QSAM Biosciences

Čomu sa venuje spoločnosť QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Firmy s metrikou účtovná hodnota akcie podobnou spoločnosti QSAM Biosciences



  • Hodnota metriky Účtovná hodnota akcie spoločnosti Backstageplay je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Resources of Australia Ltd je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Dragontail Systems je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Paleo Resources je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Ezagoo je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Monarca Minerals je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti QSAM Biosciences je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Newtopia je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Oceanic Wind je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti 22nd Century Inc je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Blockchain Industries je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Pareteum Corp je -0.01
  • Hodnota metriky Účtovná hodnota akcie spoločnosti Pareteum Corp je -0.01